Expertise in
3
conditions

Evgueniy Hadjiev

Sofia, BG 
Expertise in
3
conditions
Sofia, BG 

Overview

Evgueniy Hadjiev practices practicing medicine in Sofia, Bulgaria.

Hadjiev is highly rated in 3 conditions, according to our data. Their clinical expertise encompasses Gaucher Disease Type 1, Gaucher Disease, Myeloproliferative Neoplasms (MPN), and Leukemia.

They are actively involved in clinical research, co-authoring 19 peer reviewed articles and participating in 2 clinical trials.

Locations

Sofia, 1431, Bulgaria
Other Locations
Bulgaria

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

An International, Phase 2, Open-Label, Randomized Study of BGB-3111 Combined With Obinutuzumab Compared With Obinutuzumab Monotherapy in Relapsed/ Refractory Follicular Lymphoma
An International, Phase 2, Open-Label, Randomized Study of BGB-3111 Combined With Obinutuzumab Compared With Obinutuzumab Monotherapy in Relapsed/ Refractory Follicular Lymphoma
Enrollment Status: Completed
Publish Date: February 18, 2026
Intervention Type: Drug
Study Drugs: Zanubrutinib, Obinutuzumab
Study Phase: Phase 2
A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura
A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura
Enrollment Status: Completed
Publish Date: December 11, 2023
Intervention Type: Drug
Study Drug: Fostamatinib
Study Phase: Phase 3
View 1 Less Clinical Trial

19 Total Publications

Inhibitory HLA-C/KIR2DL2 Interactions and KIR Allelic Polymorphisms Are Associated With Susceptibility to Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.
Inhibitory HLA-C/KIR2DL2 Interactions and KIR Allelic Polymorphisms Are Associated With Susceptibility to Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.
Journal: EJHaem
Published: June 06, 2026

Frequently Asked Questions about Evgueniy Hadjiev

Is Evgueniy Hadjiev a top-rated expert for Gaucher Disease Type 1?

MediFind is an objective health platform that identifies experts based on real-world data. Evgueniy Hadjiev is classified as an Distinguished expert for Gaucher Disease Type 1, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Evgueniy Hadjiev participate in research or clinical trials?

Yes. Evgueniy Hadjiev has published 19 articles and abstracts on conditions like Gaucher Disease Type 1. You can view a list of Evgueniy Hadjiev's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Hadjiev's expertise for a condition
ConditionClose
    View All 7 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile